Other Pharmaceuticals - Turkmenistan
Turkmenistan- The Other Pharmaceuticals market in Turkmenistan is expected to see a significant increase in revenue, with projections indicating that it will reach US$157.13m in 2025.
- Furthermore, it is anticipated that the market will continue to grow at a steady pace, with an annual growth rate (CAGR 2025-2029) of 5.15%.
- This growth trajectory is expected to result in a market volume of US$192.10m by 2029.
- When compared globally, it is worth noting that United States is projected to generate the highest revenue in this market, with an estimated amount of US$270.12bn in 2025.
- The Turkmenistani market for other pharmaceuticals is seeing a surge in demand due to the government's focus on improving healthcare infrastructure and increasing access to medication.
- Key regions:
- China,
- Europe,
- Australia,
- United States,
- Germany
Definition:
The market Other Pharmaceuticals covers revenues for areas that are not specifically mentioned in the other markets, such as psychotropic or gastroenterology drugs and less expensive but widely used drugs, such as cold and cough remedies or analgesics.
Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).
In-Scope
- Psychotropic drugs
- Gastroenterology
- Cold and cough remedies
- Antibiotics
- Women's health
- Analgesics
Out-Of-Scope
- Veterinary drugs
- Medical devices
